New Delhi: Aurobindo Pharma Limited has announced that the United States drug regulator has classified Unit-IV of its wholly owned subsidiary APL Healthcare Limited as "Voluntary Action Indicated" ...

Three people were arrested and a large amount of marijuana seized in a drug bust in Sunset Tuesday evening, authorities said.

A single intravenous ketamine infusion was safe and well-tolerated in older adults with mild cognitive impairment (MCI) and depression (MCI-D), with no serious adverse events (AEs) reported, a small ...

Initiated higher-dose CBeyond Expansion Study (Part C) to generate higher-exposure human safety and pharmacokinetic data with 400 mg and 600 mg ...

An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant ...

Yuviwel, a once-weekly injection, will now compete for market share with BioMarin’s lucrative daily shot Voxzogo.

Drinkwater, an Oakland resident, allegedly fled from police, crashed his car, then attempted to steal a vehicle from another ...

Kansas health regulators issued a joint warning on Wednesday, Feb. 25, saying many retail IV therapy clinics are likely ...

The Kansas Board of Healing Arts and Board of Pharmacy published a joint statement Wednesday highlighting concerns with ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a ...

Bracco, a global leader in diagnostic imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved the extension of the current VUEWAY ® (gadopiclenol) solution for injection ...

Rybrevant Faspro is a subcutaneous co-formulation of amivantamab, a bispecific EGFR-directed and MET receptor-directed antibody, and hyaluronidase.